Rua Bioscience Limited (NZE:RUA)

New Zealand · Delayed Price · Currency is NZD

0.0340

-0.0010 (-2.86%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions NZD. Fiscal year is July - June.

Millions NZD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
Research and Development and The Sale of Pharmaceutical Products	1.83M	316.35K	668.48K	645.10K	359.34K
Research and Development and The Sale of Pharmaceutical Products Growth	477.39%	-52.68%	3.63%	79.52%	-
Total	1.83M	316.35K	668.48K	645.10K	359.34K
Total Growth	477.39%	-52.68%	3.63%	79.52%	-

Revenue by Geography

Financials in millions NZD. Fiscal year is July - June.

Millions NZD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019
New Zealand	439.72K	2.25K	-	-	359.34K
New Zealand Growth	19451.80%	-	-	-	-
Australia	584.65K	83.59K	-	-	-
Australia Growth	599.44%	-	-	-	-
Germany	486.91K	-	-	-	-
Total	1.51M	85.84K	-	-	359.34K
Total Growth	1660.64%	-	-	-	-

Source: S&P Global Market Intelligence.